Donato, Shirlyn C.

HRN: 04-41-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2024
CEFUROXIME 1.5GM (VIAL)
05/13/2024
05/13/2024
IV
1.5gm
SD
Prior To OR For TAHBSO
Waiting Final Action 
05/13/2024
CEFUROXIME 1.5GM (VIAL)
05/13/2024
05/14/2024
IV
1.5g
Q8
Tahbso
Waiting Final Action 
05/14/2024
CEFUROXIME 500MG (TAB)
05/14/2024
05/20/2024
PO
500mg
BID
S/P TAHBSO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: